Expression in ProstateCancerCells:TheRole of Bone Microenvironment-AssociatedCXCL12

BACKGROUND. Hematopoietic cells home to bone bymeans of chemo-attraction to marrow chemokines, and interaction of chemokines with their receptors leads to the expression/ activation of adhesion molecules and proteases. Recent evidence suggests that similar mechanisms may be active in cancer metastasis. Previously, we showed that metalloproteases (MMPs), and in particular MMP-9, play a role in prostate cancer (PC) expansion in bone. METHODS. Weusedavariety ofmethods includingRT-PCR, immunohistochemistry, ELISA, gelatin zymography, cellular motility and invasion, and subcellular fractionation of PC cells applied to in vivo and in vitro models. RESULTS. Here we showed that (a) CXCL12/CXCR4 axis is expressed in PC bonemetastasis; (b) exogenous CXCL12 inducedMMP-9 expression by PC cells; (c) bone stromal cells and bone tissue conditioned media induced the migration of PC cells in a CXCR4-dependent manner; (d) pharmacological inhibition of PI3 kinase and MAP kinase pathways abrogated CXCL12induced MMP-9 expression and invasion of PC cells; (e) exogenous CXCL12 induced Akt1 phosphorylation is indispensable for proMMP-9 secretion, migration, and invasion of PC cells; (f) CXCR4 was localized to lipid rafts in PC cells and initiated Akt phosphorylation. CONCLUSIONS. These data suggest that chemoattractive mechanisms involve migration of cancer cells towards bone tissue, and that cell signaling induced by binding of the chemokine to its receptor leads to the activation of multiple signaling pathways and subsequent secretion of MMP-9 into the local environment. These findings provide a link between chemoattractive mechanisms, growth of tumor cells in bone, and tumor-enhancedbonematrix turnover.Prostate 66: 32–48, 2006. # 2005 Wiley-Liss, Inc.

[1]  D. Taub,et al.  Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. , 2005, Experimental cell research.

[2]  Bonnie F. Sloane,et al.  Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. , 2005, The American journal of pathology.

[3]  Shailesh Singh,et al.  CXCL12–CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion , 2004, Laboratory Investigation.

[4]  Brian Barnett,et al.  Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals , 2004, Cancer Research.

[5]  M. Kruhøffer,et al.  Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas , 2004, Oncogene.

[6]  N. Dolloff,et al.  CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells , 2004, Cancer Research.

[7]  A. Mantovani,et al.  Chemokines in neoplastic progression. , 2004, Seminars in cancer biology.

[8]  Tae-Hee Lee,et al.  Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. , 2004, Molecular cancer research : MCR.

[9]  A. Poggi,et al.  Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. , 2004, Blood.

[10]  Y. Rao,et al.  Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells* , 2004, Journal of Biological Chemistry.

[11]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[12]  H. Yoshida,et al.  Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. , 2003, Experimental cell research.

[13]  H. Moch,et al.  Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL , 2003, Nature.

[14]  P. Collin‐Osdoby,et al.  Stromal Cell‐Derived Factor‐1 (SDF‐1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase‐9 (MMP‐9) Activity, and Collagen Transmigration , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  A. Nagler,et al.  HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. , 2003, The Journal of clinical investigation.

[16]  J. Benovic,et al.  The ins and outs of G protein-coupled receptor trafficking. , 2003, Trends in biochemical sciences.

[17]  Ed Roos,et al.  The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. , 2003, Cancer research.

[18]  K. Pienta,et al.  Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo , 2003, Journal of cellular biochemistry.

[19]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[20]  R. Bonavia,et al.  Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. , 2003, Cancer research.

[21]  R. Ganju,et al.  Differential Regulation of CXCR4-mediated T-cell Chemotaxis and Mitogen-activated Protein Kinase Activation by the Membrane Tyrosine Phosphatase, CD45* , 2003, The Journal of Biological Chemistry.

[22]  V. Wee Yong,et al.  CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.

[23]  I. Fidler,et al.  The organ microenvironment and cancer metastasis. , 2002, Differentiation; research in biological diversity.

[24]  Gordon Stamp,et al.  Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. , 2002, Cancer research.

[25]  Oana A. Tomescu,et al.  CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. , 2002, Blood.

[26]  I. Petit,et al.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. , 2002, Experimental hematology.

[27]  B. Hemmings,et al.  Identification of a Plasma Membrane Raft-Associated PKB Ser473 Kinase Activity that Is Distinct from ILK and PDK1 , 2002, Current Biology.

[28]  Giovanni Martinelli,et al.  CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. , 2002, Cancer research.

[29]  Nils Brünner,et al.  Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[31]  H. Chap,et al.  Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway. , 2002, Biochimica et biophysica acta.

[32]  M. Freeman,et al.  Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. , 2002, Cancer research.

[33]  Evan T Keller,et al.  Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. , 2002, Cancer research.

[34]  R. Fridman,et al.  Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis. , 2002, Journal of the National Cancer Institute.

[35]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[36]  C. Cohen,et al.  Chemokine-Induced Secretion of Gelatinase B in Primary Human Monocytes , 2001, Biological chemistry.

[37]  R. Fridman,et al.  Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells , 2001, International journal of cancer.

[38]  Sang-Oh Yoon,et al.  Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells* , 2001, The Journal of Biological Chemistry.

[39]  M. Ittmann,et al.  Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. , 2001, Cancer research.

[40]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[41]  Terry L. Smith,et al.  Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial , 2001, The Lancet.

[42]  S. Rafii,et al.  Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. , 2000, Blood.

[43]  M. Ratajczak,et al.  Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. , 2000, Experimental hematology.

[44]  Kai Simons,et al.  Lipid rafts and signal transduction , 2000, Nature Reviews Molecular Cell Biology.

[45]  H. Moch,et al.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. , 2000, Human pathology.

[46]  M. Ratajczak,et al.  Binding of stromal derived factor‐1α(SDF‐1α) to CXCR4 chemokine receptorin normal human megakaryoblasts butnot in platelets induces phosphorylationof mitogen‐activated protein kinase p42/44 (MAPK), ELK‐1 transcription factor and serine/threonine kinase AKT , 2000, European journal of haematology.

[47]  K. Moelling,et al.  Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.

[48]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[49]  W. Liu,et al.  Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines* , 1999, The Journal of Biological Chemistry.

[50]  J. Westermarck,et al.  Regulation of matrix metalloproteinase expression in tumor invasion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  D. Grignon,et al.  Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. , 1999, Cancer research.

[52]  S. Bagrodia,et al.  Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac , 1998, Molecular and Cellular Biology.

[53]  R. Doms,et al.  CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.

[54]  E. Ruoslahti,et al.  Integrins and tumor cell dissemination. , 1989, Cancer cells.

[55]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[56]  M. Ratajczak,et al.  Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. , 2005, Blood.

[57]  R. Alon,et al.  Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. , 2005, The Journal of clinical investigation.

[58]  Yiwei Li,et al.  Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells. , 2005, Frontiers in bioscience : a journal and virtual library.

[59]  R. Fridman,et al.  Matrix metalloproteinaes and bone metastasis. , 2004, Cancer treatment and research.

[60]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[61]  L. Mayo,et al.  Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. , 2004, The Journal of biological chemistry.

[62]  M. Freeman,et al.  Cholesterol and prostate cancer , 2004, Journal of cellular biochemistry.

[63]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[64]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[65]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.